Journal of the Korean Society of Food Science and Nutrition (한국식품영양과학회지)

The Korean Society of Food Science and Nutrition (한국식품영양과학회)
권호 표지
DOI QR코드

DOI QR Code

Studies of Morphological Properties and Pyrrolizidine Alkaloids Analysis of Comfrey Cultivating in Korea

국내산 컴프리의 형태학적 특성 및 Pyrrolizidine Alkaloids 분석

  • Published : 2003.08.01
Download PDF
⟨ Previous Next ⟩

Abstract

This study was carried out to investigate the morphological properties and pyrrolizidine alkaloids of comfrey cultivating in Korea. 12 comfrey samples cultivation in Korea was selected and their appearance (whole plant, leaves, root etc.) were observed by expert and microscopy for morphological analysis. It is confirmed that their species are Symphytum officinale Linnaeus. Samples were extracted by hot MeOH and ultra-sonification. Their extracts contained pyrrolizidine alkaloids, which was identified by TLC analysis. By spraying thin-layer chromatograms of pyrrolizidine alkaloids stable purple spots were developed. But the extracts of chicory, pumpkin and sesame leaves did not show any purple spots. Same HPLC pattern were displayed at about 30 min of retention show peaks an one and the same time.

본 연구에서는 국내에서 재배되고 있는 컴프리의 형태학적 특성 및 pyrrolizidine alkaloids을 분석하기 위해서 수행되었다. 국내에서 채취한 12개 지역의 컴프리를 대상으로 형태학적 인 연구를 실시한 결과 모두 한 종류의 Symphytum officinale임을 확인할 수 있었다. 또한 이들 시료를 hot methanol과 ultra-sonification으로 추출하여 pyrrolizidine alka loids 함유 여부를 확인하기 위하여 TLC 시험을 실시한 결과, 12개 시료의 컴프리는 o-chloranil과 Ehrlich's reagent의 발색시약이 pyrrolizidine alkaloids와 반응하여 특이적인 purple spot을 나타내었다. 그러나 치커리, 호박잎 및 깻잎을 사용하여 동일한 시험을 실시한 결과 purple spot이 관찰되지 않음을 알 수 있었다. HPLC 패턴을 분석 결과, 12개 시료의 컴프리는 retention time 30 부근에 특이적인 peak를 나타내었으나, 치커리, 호박잎 및 깻잎은 peak를나타내지 않았다. 따라서 국내 재배중인 컴프리 12종은 형태학적 특성 및 pyrrolizidine alkaloids로 조사한 결과, S. officinale 종임을 확인할 수 있었다.

Keywords

References

  1. 김태정. 1996. 한국의 자원식물 III. 서울대학교 출판부, 서울. p 303.
  2. 두산동아. 1999. 두산세계대백과사전. Vol 25, p 324.
  3. Mattocks AR. 1980. Toxic pyrrolizidine alkaloids in comfrey. Lancet 22: 1136-1137.
  4. Couet CE, Crews C, Hanley AB. 1996. Analysis, separation, and bioassay of pyrrolizidine alkaloids from comfrey (Symphytum officinale). Natural Toxins 4: 163-167. https://doi.org/10.1002/19960404NT3
  5. Abbott PJ. 1988. Comfrey: assessing the low-dose health risk. Med J Aust 149: 678-682.
  6. Betz JM, Eppley RM, Taylor WC, Andrzejewski D. 1994. Determination of pyrrolizidine alkaloids in commercial comfrey products (Symphytum sp.). J Pharm Sci 83: 649-653. https://doi.org/10.1002/jps.2600830511
  7. Roeder E. 2000. Medicinal plants in China containing pyrrolizidine alkaloids. Pharmazie 55: 711-726.
  8. Huxtable RJ. 1992. The myth of beneficent nature: the risks of herbal preparations. Ann Intern Med 117: 165-166. https://doi.org/10.7326/0003-4819-117-2-165
  9. Danninger T, Hagemann U, Schmidt V, Schoenhoefer PS. 1983. Toxicity of pyrrolizidine alkaloid-containing medicinal plants. Pharm Ztg 128: 289-303.
  10. Hartmann T, Zimmer M. 1986. Organ-specific distribution and accumulation of pyrrolizidine alkaloids during the life history of 2 annual Senecio species. J Plant Physiol 122: 67-80. https://doi.org/10.1016/S0176-1617(86)80085-2
  11. Mattocks AR. 1986. Chemistry and toxicology of pyrrolizidine alkaloids. Academic Press, London, New York.
  12. Russell JM, Roitman JN. 1980. Specific detection of pyrrolizidine alkaloids on thin-layer chromatograms. J Chromatography A 195: 412-415. https://doi.org/10.1016/S0021-9673(00)81478-8
  13. WHO. 1988. Pyrrolizidine Alkaloids. World Health Organization, Geneva.
  14. U.S. FDA Center for Food Safety and Applied Nutrition. Pyrrolizidine Alkaloids. http://www.cfsan.fda.gov/～mow/chap42.html.
  15. Tyler VE. 1993. The honest herbal: a sensible guide to the use of herbs and related remedies. 3rd ed. The Haworth Press, New York. p 97-100.
  16. Yeong ML, Clark SP, Waring JM, Wilson RD, Wakefield, SJ. 1991. The effects of comfrey derived pyrrolizidine alkaloids on rat liver. Pathology 23: 35-38. https://doi.org/10.3109/00313029109061438
  17. Stickel F, Seitz HK. 2000. The efficacy and safety of comfrey. Public Health Nutr 3: 501-508.
  18. Stickel F, Seitz HK, Hahn EG, Schuppan D. 2001. Liver toxicity of drugs of plant origin. Z Gastroenterol 39: 225-232, 234-247. https://doi.org/10.1055/s-2001-11772
  19. Steenkamp V, Stewart MJ, Zuckerman M. 2000. Clinical and analytical aspects of pyrrolizidine poisoning caused by South African traditional medicines. Ther Drug Monit 22: 302-306. https://doi.org/10.1097/00007691-200006000-00011
  20. Prakash AS, Pereira TN, Reilly PE, Seawright AA. 1999. Pyrrolizidine alkaloids in human diet. Mutat Res 15: 443, 53-67.
  21. US FDA. 1993. Illnesses and Injuries Associated With the Use of Selected Dietary Supplements, U.S. FDA Center for Food safety and Applied Nutrition.
  22. Huxtable RJ. 1989. Toxicants of plant origin. Cheeke PR, ed. CRC Press Inc., Boca Raton, FL. Vol 1, Chapter 3, p 41-86.
  23. US FDA. July 6, 2001. FDA advises dietary supplement manufacturers to remove comfrey products from the market. http://www.cfsan.fda.gov/～dms/dspltr06.html.
  24. 식품의약품안전청. 2001. 제3. 식품일반에 대한 공통기준 및 규격. 식품공전. p 31.
  25. 식품의약품안전청. 2001.8.6. 식품의 기준 및 규격중 개정안 입안예고. 식품의약품안전청공고 제2001-71호.
  26. Cooper RA, Bowers RJ, Beckham CJ, Huxtable RJ. 1996. Preparative separation of pyrrolizidine alkaloids by highspeed counter-current chromatography. J Chromatography A 732: 43-50. https://doi.org/10.1016/0021-9673(95)01241-9
  27. Molyneux RJ, Rottman JN. 1980. Specific detection of pyrrolizidine alkaloids on thin-layer chromatograms. J Chromatography 195: 412-415. https://doi.org/10.1016/S0021-9673(00)81478-8